In spinal surgery, the rate of postoperative deep wound infection depends on the type of surgery and on patients\' premorbidity, and ranges from 0.7% for simple nucleotomy to over 3.5% for fusion with instrumentation, and can reach 20% in patients with metastatic disease ([@CIT0018], [@CIT0017]). Early detection of postoperative infection, especially in spine surgery, can be difficult. Numerous plasma values have been used in monitoring of infection-related responses after spine surgery. These plasma determinations range from simple and inexpensive tests such as erythrocyte sedimentation rate (ESR) ([@CIT0016], [@CIT0009]) to the complex determination of soluble biomarkers of inflammatory response such as quantification of cytokines ([@CIT0005]). The value of ESR as an early marker of infection has been disputed ([@CIT0008], [@CIT0009], [@CIT0006]) and the latter methods are complicated and difficult to interpret, and are also very expensive.

The acute-phase-related C-reactive protein (CRP) is a feasible parameter for detection and monitoring of postoperative wound infections and systemic inflammatory response syndromes ([@CIT0003], [@CIT0011], [@CIT0015]). Serial CRP measurements are useful not only as a diagnostic tool for infection, but also for monitoring the effect of treatment and for the early detection of relapse ([@CIT0008], [@CIT0001], [@CIT0010]). As with other orthopedic surgical procedures, surgery of the spine induces a temporary rise in CRP ([@CIT0004], [@CIT0011], [@CIT0010]). One prerequisite for the use of CRP as a diagnostic aid after spine surgery in the early detection of postoperative infection is an understanding of the natural CRP response induced by the procedure. To establish this baseline, we examined CRP levels and white blood cell (WBC) count after 2 types of surgical procedures of the lumbar spine. In addition, we assessed the degree to which postoperative CRP kinetics is influenced by patient comorbidity and by perioperative administration of prophylactic antibiotics.

Patients and methods {#ss2}
====================

We retrospectively assessed 1,320 patients who underwent surgery of the spine at our university hospital during 2001--2004, and for this study selected patients (aged over 18 years) who received single-level fusion for lumbar spinal stenosis (fusion) and single-level nucleotomy for herniated lumbar disc (nucleotomy). Only patients with normal levels of CRP before surgery were included. Exclusion criteria were staged procedures, surgery for infection, postoperative hematoma, history of autoimmune or inflammatory disorders, hepatitis or liver disease, tumor or cancer, or infectious complications after surgery. 347 patients (150 fusion, 197 nucleotomy) met the inclusion criteria and were included in the study. Comorbidity information and the ASA score were obtained from the preoperative history, records of physical examination, and anesthesia records. We also recorded region of lumbar surgery, type of procedure, operative time from skin incision to closure, estimated blood loss, and whether or not prophylactic antibiotics were administered.

Surgery {#ss3}
-------

All procedures were performed under general anesthesia. Patients receiving antibiotics were treated with cefazolin (1 g) intravenously within 1 h of skin incision, and for those with nucleotomy in the form of a single-shot administration; in those with fusion surgery, administration of antibiotics was continued every 8 h over 24 h postoperatively. In the presence of a penicillin allergy, clindamycin was used instead of cefazolin.

Surgical management of herniated lumbar disc was performed by a minimally invasive endoscopically-assisted technique using the endospine system (Karl Storz, Tuttlingen, Germany) as described by [@CIT0002]. The steps of the procedure and the iatrogenic trauma to paraspinal muscle are comparable to the widely used method of limited lumbar microdiscectomy using an operating microscope. Patients who received single-level fusion for spinal stenosis were treated using a 360° posterior lumbar interlaminar fusion (PLIF) technique. After sufficient spinal canal decompression, 4 transpedicular screws (XIA Spine System; Stryker, Kalamazoo, MI) were placed under fluoroscopic control. After complete removal of the disc space and freshening of the adjacent endplates, 2 polyetheretherketone (PEEK) cages (PLIF Spine System, Stryker) filled with bone graft harvested from the removed spinous process were fitted. Over the rods, compression was applied to the anterior cages and the rods were then firmly fixed to screws to achieve a stable 360° instrumentation.

In all patients, blood specimens were obtained on the day before surgery and on the day after surgery. Four further specimens were taken on days 2 or 3, 4--6, 7--9, and 10--14 after the procedure. The samples were obtained at approximately the same time each morning. Serum CRP was quantified by the CardioPhase high- sensitivity C-reactive protein (CCRP) method with heterogeneous immunoassay (CardioPhase high-sensitivity CRP, Siemens Healthcare Diagnostics, Marburg, Germany). White blood cell count was obtained using flow cytometry (Siemens Healthcare Diagnostics).

Statistics {#ss4}
----------

Continuous variables such as age, body weight, duration of surgery, and the peak values of the inflammatory parameters are given as mean (SD). The difference between the two treatment modalities regarding CRP and WBC were assessed using Wilcoxon rank-sum tests. Categorical variables were presented in frequencies (relative frequencies), and the heterogeneities between the groups were tested using Chi-square test or Fisher\'s exact test, as appropriate, if the expected frequencies were less than 5. Probability values were not adjusted for the multiple testing. To estimate the effect of treatment modality on the peak values of inflammatory parameters with adjustment for the potential confounding factors, multifactorial linear regression models were used. The statistically significant factors (p \< 0.05) regarding general characteristics in the univariate analyses (cf. [Table 1](#T1){ref-type="table"}) were included in the model, in addition to the baseline values of the same parameters. The analyses were performed using SAS software version 8.2 (SAS Institute Inc., Cary, NC).

###### 

General patient characteristics (n = 347), medical history, and comorbidities

  General characteristics                Nucleotomy    Fusion surgery   p-value
  -------------------------------------- ------------- ---------------- ----------
  Age, years                             47 (15)       55 (15)          \< 0.001
   Gender, male                          99 (50%)      76 (51%)         1.0
   Body weight, kg                       79.3 (18)     79.3 (15)        0.9
   BMI \> 25                             39 (20%)      44 (29%)         0.04
   Duration of surgery, h                0.86 (0.65)   2.32 (1.16)      \< 0.001
  Antibiotic treatment                                                  
   Preoperative administration (24 h)    0 (0%)        4 (2.7%)         0.03
   Single-shot intraoperatively          65 (33%)      120 (80%)        \< 0.001
   Postoperative administration (24 h)   45 (23%)      117 (78%)        \< 0.001
  Comorbidities and prior surgery                                       
   Diabetes mellitus                     9 (4.6%)      8 (5.3%)         0.80
   Arterial hypertension                 24 (12%)      49 (33%)         \< 0.001
   Coronary heart disease                4 (2.0%)      10 (6.7%)        0.05
   History of thrombosis                 2 (1.0%)      2 (1.3%)         1.0
   History of hip surgery                2 (1.0%)      2 (1.3%)         1.0
   History of knee surgery               6 (3.1%)      3 (2.0%)         0.7
   History of abdominal surgery          6 (3.1%)      2 (1.3%)         0.5
   History of nucleotomy                 17 (8.6%)     12 (8.0%)        1.0
  ASA classification                                                    
   I                                     72 (37%)      21 (14%)         \< 0.001
   II                                    21 (11%)      30 (20%)         0.05
   III                                   104 (53%)     98 (65%)         0.02
   IV                                    0 (0%)        1 (0.7%)         \< 0.001
   V                                     0 (0%)        0 (0%)           NA

The p-values are means from Chi-square or Fisher\'s exact tests. Age, body weight, and duration of surgery are given as mean (SD). The p-values are derived from Wilcoxon rank-sum tests. The heterogeneities of sex and obesity were tested with Chi-square tests. NA: Not applicable .

Results {#ss5}
=======

347 patients met the inclusion criteria and were included in the study ([Table 1](#T1){ref-type="table"}).

Kinetics of CRP {#ss6}
---------------

Preoperative baseline values of CRP were normal: 3.0 (SD 3.1) mg/L for patients treated with nucleotomy (n = 197) and 4.3 (SD 4.6) mg/L for those treated with fusion (n = 150). For both types of surgery a characteristic postoperative CRP pattern was observed, although the maximum amplitude varied between the procedures. In 90% of patients who underwent nucleotomy (178/197) and in 81% of patients with fusion (122/150), peak CRP values were reached between days 2 and 3 postoperatively (p = 0.02, Fisher\'s exact test). While maximum CRP values after nucleotomy increased approximately 25 fold to 75 (SD 48) mg/L, the increase was higher after fusion, with an approximately 30-fold increase to 127 (SD 58) mg/L relative to baseline values ([Table 2](#T2){ref-type="table"}). This discrepancy in peak CRP levels was statistically significant (p = 0.007). Peak CRP values after both procedures were followed by a rapid decrease in all patients. At the 4--6-day control, the mean value was 23 (SD 28) mg/L after nucleotomy and 60 (SD 42) mg/L after fusion. At the 10--14-day control, the mean values were 7.1 (SD 6.8) mg/L after nucleotomy and 10 (SD 6.8) mg/L after fusion, thus approaching normal values (\< 5 mg/L) ([Figure 1](#F1){ref-type="fig"}).

###### 

Mean profiles of CRP and leukocyte values preoperatively and postoperatively

                       Nucleotomy   Fusion surgery   p-value
  -------------------- ------------ ---------------- ----------
  *CRP (mg/L)*                                       
   Preoperatively      3.0 (3.1)    4.3 (4.6)        \< 0.001
   Day 1               41 (27)      70 (34)          \< 0.001
   Day 2--3            75 (48)      127 (58)         0.007
   Day 4--6            23 (29)      60 (42)          \< 0.001
   Day 7--9            13 (19)      29 (34)          \< 0.001
   Day 10--14          7.1 (9.6)    10 (6.8)         \< 0.001
  *Leukocytes (G/L)*                                 
   Preoperatively      8.5 (2.9)    7.8 (2.8)        0.02
   Day 1               9.3 (3.2)    10.1 (3.0)       0.01
   Day 2--3            9.9 (4.4)    9.5 (2.7)        0.6
   Day 4--6            7.2 (2.5)    7.3 (2.7)        0.8
   Day 7--9            7.3 (2.4)    8.1 (2.7)        0.08
   Day 10--14          8.1 (2.5)    8.0 (3.0)        0.6

The inflammatory parameters are summarized as mean (standard deviation). The p-values were derived from Wilcoxon rank-sum tests.

![Kinetics of postoperative CRP levels (mg/L): fusion (n = 150) vs. nucleotomy (n = 197). Values are mean and standard deviation.](ORT-0300-9734-082-489_g001){#F1}

Leukocyte kinetics {#ss7}
------------------

Preoperative baseline values of WBC count were normal and approximately the same (8.5 (SD 2.9) g/L) for patients treated with nucleotomy or fusion. For both types of surgery, leukocyte count had a characteristic pattern: the maximum amplitude varied statistically significantly between the two procedures only on the first postoperative day ([Table 2](#T2){ref-type="table"}). Maximum leukocyte counts were back to or below preoperative values between 4--6 days after surgery ([Figure 2](#F2){ref-type="fig"}).

![Kinetics of postoperative white blood cell count (g/L): fusion (n = 150) vs. nucleotomy (n = 197). Values are mean and standard deviation.](ORT-0300-9734-082-489_g002){#F2}

Influence of comorbidities and surgery time {#ss8}
-------------------------------------------

Using multiple regression analysis, we assessed whether there might be any correlation between peak inflammatory parameters and comorbidities. In neither of the cohorts did diabetes mellitus, arterial hypertension, compensated heart insufficiency, nor a history of prior lumbar nucleotomy in another segment have any influence on CRP or leukocyte kinetics postoperatively compared to patients without these comorbidities ([Table 3](#T3){ref-type="table"}). Surprisingly, ASA classification as a parameter of patients\' overall health status and history of spine surgery were not found to affect postoperative peak CRP values or leukocyte values (or their normalization). In contrast, duration of surgery had a statistically significant influence on postoperative peak values of CRP and leukocytes: the longer the surgery, the higher the peak levels (p = 0.04). While we found an association between obesity (BMI \> 25) and postoperative peak CRP levels, we found no association between obesity and leukocyte values ([Table 3](#T3){ref-type="table"}).

###### 

Multiple regression analysis of peak values of CRP and leukocyte profiles for all patients (n = 347)

                         Peak CRP       Peak leukocytes
  ---------------------- -------------- -----------------
  Multiple regression    0.28           0.62
   F-value               23             99
   p-value               \< 0.001       \< 0.001
  Intercept                             
   Coefficient (SE)      4.89 (8.6)     1.56 (0.50)
   p-value               0.6            0.002
  OP procedure                          
   Coefficient (SE)      30 (7.3)       0.35 (0.32)
   p-value               \< 0.001       0.27
  Surgical duration                     
   Coefficient (SE)      5.9 (2.9)      0.50 (0.13)
   p-value               0.04           \< 0.001
  Baseline value                        
   Coefficient (SE)      2.5 (0.7)      0.81 (0.04)
   p-value               0.001          \< 0.001
  Perioperative AB use                  
   Coefficient (SE)      --0.83 (5.7)   0.02 (0.25)
   p-value               0.9            0.9
  Obesity                               
   Coefficient (SE)      14 (5.9)       --0.06 (0.25)
   p-value               0.02           0.8

SE: standard error.

Multifactorial linear regression models were used

Influence of antibiotics {#ss9}
------------------------

Regression analysis showed that administration of antibiotics did not have any influence on peak serum CRP or leukocyte values. We did not find any delay in recovery of these values after antibiotic treatment.

Discussion {#ss10}
==========

Analogous to what has been found for other surgical procedures, we observed a rise in CRP on day 1 after elective spine surgery and peaks in CRP between days 2 and 3 after intervention, indicating a major inflammatory response. The intensity of this operative peak was individual and it was of no prognostic relevance. Even so, while peak values varied significantly between individuals, there was a remarkable resemblance in CRP profiles between patients subjected to the same procedure. In a fairly small patient series (n = 149) with varying types of spinal procedures, [@CIT0010]) found that postoperative CRP kinetics in spine surgery appeared to be similar regardless of operation, magnitude, or region. We share their opinion that peak values serve only as a reference value for the future time course. Independently of the type of spine surgery, CRP levels then fall rapidly. If this is not the case and CRP levels are persistently high at the 5--7-day control, it is indicative of an infectious complication. As suggested by [@CIT0016]), a rapid decline in CRP levels after spine surgery will be interrupted by a second rise or persistent elevation if infection occurs. Of the 1,320 patients who underwent a spinal procedure in our university hospital, most of them with an infectious complication (3.1%, n = 41) showed a steady postoperative increase in CRP levels, frequently accompanied by persistent back pain and/or local signs of wound infection (data not shown).

That different surgical procedures have varying inflammatory peak responses is not new. In orthopedic surgery, maximum postoperative CRP levels depend heavily on the region and type of surgery performed ([@CIT0008], [@CIT0016], [@CIT0007], [@CIT0012], [@CIT0011]). In general, this varying peak response depends on the amount of iatrogenic tissue injury at surgery. We found the same in our study. However, [@CIT0008]) compared different types of orthopedic surgical procedures and could not always find a correlation between the extent of surgery and peak CRP levels postoperatively. They postulated that the increase in CRP depends not only on the amount of tissue injured but also on the type of tissue being damaged.

Numerous factors favor CRP as being a more effective laboratory test than WBC count. CRP level is stable for an individual, and has a narrow normal range. It is hardly influenced by drugs and---as we found also---it appears that prior spine surgery, common comorbidities, or pathologies (apart from liver failure) have no effect ([@CIT0013]). On the other hand, determination of WBC count is considerably less expensive. In instrumented spinal surgery especially, it is, however, only of interpretational value in combination with erythrocyte sedimentation rate (ESR), body temperature, and CRP levels---even in cases with proven infectious complications ([@CIT0014]). Our data highlight the fact that in contrast to CRP, WBC count after complication-free spinal surgery does not show a typical (and therefore interpretable) profile, making it of secondary value only as a serum parameter for early detection of infectious complications.

Since it has been shown that there is a correlation between serum CRP levels and clinical response in patients treated with antibiotics for wound infections after spinal surgery ([@CIT0006]), we wanted to know whether prophylactic perioperative administration of antibiotics reduces the interpretational value of postoperative CRP values. This was not the case, which is important from a clinical point of view. Administration of antibiotics over a short period of time perioperatively does not affect CRP values.

For clinical practice in patients undergoing elective spine surgery, we suggest routine measurement of serum CRP levels on the day before surgery, and on days 2--3 and 4--6 postoperatively. With no clinical findings suspect for infection a marked drop in CRP-values on the 4-6 postoperative day, further testing may not be necessary. In cases where CRP values do not rapidly decrease, a wound infection after spinal surgery must be considered, as clinical signs may be lagging behind. However, other postoperative infectious complications such as urinary tract infections or pneumonia may also cause high CRP values and need to be recognized.

A large prospective randomized trial is necessary to establish whether the time periods we suggest for measurement of CRP are sufficient for early detection of infectious complications after spinal surgery. The same study may answer the question as to how many delayed infectious complications (after day 6) are missed by minimizing CRP-controls as propagated above.
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